Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1997 Apr 29;949:4318-23. doi: 10.1073/pnas.94.9.4318.
Show Gene links
Show Anatomy links
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
Kliewer SA
,
Sundseth SS
,
Jones SA
,
Brown PJ
,
Wisely GB
,
Koble CS
,
Devchand P
,
Wahli W
,
Willson TM
,
Lenhard JM
,
Lehmann JM
.
???displayArticle.abstract???
Peroxisome proliferator-activated receptors (PPARs) alpha and gamma are key regulators of lipid homeostasis and are activated by a structurally diverse group of compounds including fatty acids, eicosanoids, and hypolipidemic drugs such as fibrates and thiazolidinediones. While thiazolidinediones and 15-deoxy-Delta12, 14-prostaglandin J2 have been shown to bind to PPARgamma, it has remained unclear whether other activators mediate their effects through direct interactions with the PPARs or via indirect mechanisms. Here, we describe a novel fibrate, designated GW2331, that is a high-affinity ligand for both PPARalpha and PPARgamma. Using GW2331 as a radioligand in competition binding assays, we show that certain mono- and polyunsaturated fatty acids bind directly to PPARalpha and PPARgamma at physiological concentrations, and that the eicosanoids 8(S)-hydroxyeicosatetraenoic acid and 15-deoxy-Delta12,14-prostaglandin J2 can function as subtype-selective ligands for PPARalpha and PPARgamma, respectively. These data provide evidence that PPARs serve as physiological sensors of lipid levels and suggest a molecular mechanism whereby dietary fatty acids can modulate lipid homeostasis.
Amri,
Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells.
1994, Pubmed
Amri,
Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells.
1994,
Pubmed
Banner,
A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma.
1993,
Pubmed
Borkman,
The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids.
1993,
Pubmed
Brun,
Differential activation of adipogenesis by multiple PPAR isoforms.
1996,
Pubmed
Catapano,
Mode of action of fibrates.
1992,
Pubmed
Chawla,
Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation.
1994,
Pubmed
Clarke,
Polyunsaturated fatty acid regulation of hepatic gene transcription.
1996,
Pubmed
Devchand,
The PPARalpha-leukotriene B4 pathway to inflammation control.
1996,
Pubmed
Dreyer,
Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.
1992,
Pubmed
,
Xenbase
Forman,
15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
1995,
Pubmed
Fürstenberger,
Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo.
1991,
Pubmed
Green,
Peroxisome proliferator-activated receptors: finding the orphan a home.
1994,
Pubmed
Grundy,
Dietary influences on serum lipids and lipoproteins.
1990,
Pubmed
Gschwendt,
Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopy.
1986,
Pubmed
Göttlicher,
Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor.
1992,
Pubmed
Hertz,
Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).
1996,
Pubmed
Hillgartner,
Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis.
1995,
Pubmed
Horrobin,
Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: a common link between risk factors and coronary and peripheral vascular disease?
1995,
Pubmed
Hughes,
Investigation of the mechanism of biosynthesis of 8-hydroxyeicosatetraenoic acid in mouse skin.
1991,
Pubmed
Issemann,
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.
1990,
Pubmed
Issemann,
The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.
1993,
Pubmed
Jüngling,
A one-vial method for routine extraction and quantification of free fatty acids in blood and tissue by HPLC.
1988,
Pubmed
Keller,
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.
1993,
Pubmed
Kliewer,
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
1994,
Pubmed
Kliewer,
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
1995,
Pubmed
Krey,
Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids.
1993,
Pubmed
,
Xenbase
Lee,
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
1995,
Pubmed
Lehmann,
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
1995,
Pubmed
Nestel,
Effects of N-3 fatty acids on lipid metabolism.
1990,
Pubmed
Nolan,
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.
1994,
Pubmed
Reddy,
Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
1986,
Pubmed
Saltiel,
Thiazolidinediones in the treatment of insulin resistance and type II diabetes.
1996,
Pubmed
Sher,
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.
1993,
Pubmed
Sirtori,
Effects of fibrates on serum lipids and atherosclerosis.
1988,
Pubmed
Storlien,
Fish oil prevents insulin resistance induced by high-fat feeding in rats.
1987,
Pubmed
Tontonoz,
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
1994,
Pubmed
Tontonoz,
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.
1994,
Pubmed
Yu,
Differential activation of peroxisome proliferator-activated receptors by eicosanoids.
1995,
Pubmed
Zhu,
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
1993,
Pubmed
,
Xenbase
